G21W (p.Gly21Trp) variant of ABL2 (Tyrosine-protein kinase ABL2)
G21W (p.Gly21Trp) in ABL2 (Tyrosine-protein kinase ABL2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.50 / 1. The record also includes population frequency data.
G21W (p.Gly21Trp) variant details
- p.Gly21Trp
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.502
- REVEL 0.39
- CADD 25.10
- PolyPhen-2 0.72
- SIFT 0.07
- UniProt: Variant assessed as somatic; moderate impact.
- Population evidence available